0001231919-25-000167.txt : 20250827 0001231919-25-000167.hdr.sgml : 20250827 20250827151333 ACCESSION NUMBER: 0001231919-25-000167 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250827 DATE AS OF CHANGE: 20250827 EFFECTIVENESS DATE: 20250827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inversion Therapeutics, Inc. CENTRAL INDEX KEY: 0002077706 ORGANIZATION NAME: EIN: 331982698 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-555986 FILM NUMBER: 251264418 BUSINESS ADDRESS: STREET 1: 1341 COLUMBUS AVENUE CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 858-550-6000 MAIL ADDRESS: STREET 1: 1341 COLUMBUS AVENUE CITY: BURLINGAME STATE: CA ZIP: 94010 D 1 primary_doc.xml X0708 D LIVE 0002077706 Inversion Therapeutics, Inc. 1341 COLUMBUS AVENUE BURLINGAME CA CALIFORNIA 94010 650-430-5176 DELAWARE None None Corporation true 2024 James A. Wells, Ph.D. 1341 Columbus Avenue Burlingame CA CALIFORNIA 94010 Executive Officer Director Jeremy Caldwell, Ph.D. 1341 Columbus Avennue Burlingame CA CALIFORNIA 94010 Director William Michael Kavanaugh, M.D. 1341 Columbus Avenue Burlingame CA CALIFORNIA 94010 Director Samad Wahid, M.D. 1341 Columbus Avenue Burlingame CA CALIFORNIA 94010 Director Biotechnology Decline to Disclose 06b false 2025-06-20 false true false 0 11110779 6910684 4200095 Total Amount Sold includes amounts paid in both cash and pursuant to conversion of indebtedness. false 4 0 0 0 false Inversion Therapeutics, Inc. /s/ James A. Wells, Ph.D. James A. Wells, Ph.D. President 2025-08-22